Terlipressin versus other vasoactive drugs for hepatorenal syndrome

BACKGROUND: Hepatorenal syndrome is defined as severe renal failure occurring in people with cirrhosis and ascites. Systematic reviews of randomised clinical trials found that, compared with placebo, terlipressin may reduce mortality and improve renal function in people with hepatorenal syndrome, bu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cochrane Database Syst Rev
Autori principali: Israelsen, Mads, Krag, Aleksander, Allegretti, Andrew S, Jovani, Manol, Goldin, Alison H, Winter, Rachel W, Gluud, Lise Lotte
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2017
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483765/
https://ncbi.nlm.nih.gov/pubmed/28953318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011532.pub2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi